Literature DB >> 8309547

Regulated cleavage of Alzheimer beta-amyloid precursor protein in the absence of the cytoplasmic tail.

O A da Cruz e Silva1, K Iverfeldt, T Oltersdorf, S Sinha, I Lieberburg, T V Ramabhadran, T Suzuki, S S Sisodia, S Gandy, P Greengard.   

Abstract

Alzheimer beta-amyloid precursor protein can be phosphorylated on residues Thr654, Ser655 and Thr668 on its cytoplasmic domain. Proteolytic cleavage of the amyloid precursor protein and release of the amyloid precursor protein ectodomain into the medium of cultured cells can be activated by phorbol esters which stimulate protein kinase C. In the present study, using mutated amyloid precursor protein, we show that phosphorylation of cytoplasmic residues is not required for the phorbol ester-activated cleavage and release of the amyloid precursor protein ectodomain. Remarkably, deletion of the entire amyloid precursor protein cytoplasmic tail had no effect on the phorbol ester-activated cleavage/release. The results indicate that activation of amyloid precursor protein cleavage/release by protein kinase C involves phosphorylation of some component of the processing pathway, instead of or in addition to the cytoplasmic tail of the amyloid precursor protein.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8309547     DOI: 10.1016/0306-4522(93)90031-a

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  21 in total

Review 1.  Sorting through the cell biology of Alzheimer's disease: intracellular pathways to pathogenesis.

Authors:  Scott A Small; Sam Gandy
Journal:  Neuron       Date:  2006-10-05       Impact factor: 17.173

2.  Rapid stimulation of amyloid precursor protein release by epidermal growth factor: role of protein kinase C.

Authors:  B E Slack; J Breu; L Muchnicki; R J Wurtman
Journal:  Biochem J       Date:  1997-10-01       Impact factor: 3.857

3.  Elevated intracellular calcium concentration increases secretory processing of the amyloid precursor protein by a tyrosine phosphorylation-dependent mechanism.

Authors:  M A Petryniak; R J Wurtman; B E Slack
Journal:  Biochem J       Date:  1996-12-15       Impact factor: 3.857

4.  Phorbol esters affect multiple steps in beta-amyloid precursor protein trafficking and amyloid beta-protein production.

Authors:  E H Koo
Journal:  Mol Med       Date:  1997-03       Impact factor: 6.354

5.  Pervanadate activation of intracellular kinases leads to tyrosine phosphorylation and shedding of syndecan-1.

Authors:  J Reiland; V L Ott; C S Lebakken; C Yeaman; J McCarthy; A C Rapraeger
Journal:  Biochem J       Date:  1996-10-01       Impact factor: 3.857

6.  Cross-species genetic screens to identify kinase targets for APP reduction in Alzheimer's disease.

Authors:  Claudia H Huichalaf; Ismael Al-Ramahi; Kyung-Won Park; Stacy D Grunke; Nan Lu; Maria de Haro; Karla El-Zein; Tatiana Gallego-Flores; Alma M Perez; Sung Yun Jung; Juan Botas; Huda Y Zoghbi; Joanna L Jankowsky
Journal:  Hum Mol Genet       Date:  2019-06-15       Impact factor: 6.150

7.  Retrieval of the Alzheimer's amyloid precursor protein from the endosome to the TGN is S655 phosphorylation state-dependent and retromer-mediated.

Authors:  Sandra I Vieira; Sandra Rebelo; Hermann Esselmann; Jens Wiltfang; James Lah; Rachel Lane; Scott A Small; Sam Gandy; Edgar F da Cruz E Silva; Odete Ab da Cruz E Silva
Journal:  Mol Neurodegener       Date:  2010-10-11       Impact factor: 14.195

8.  S655 phosphorylation enhances APP secretory traffic.

Authors:  Sandra Isabel Vieira; Sandra Rebelo; Sara Catarina Domingues; Edgar F da Cruz e Silva; Odete A B da Cruz e Silva
Journal:  Mol Cell Biochem       Date:  2009-04-21       Impact factor: 3.396

Review 9.  Protein phosphorylation and APP metabolism.

Authors:  Edgar F da Cruz e Silva; Odete A B da Cruz e Silva
Journal:  Neurochem Res       Date:  2003-10       Impact factor: 3.996

10.  Inhibition of protein phosphatase 1 stimulates secretion of Alzheimer amyloid precursor protein.

Authors:  E F da Cruz e Silva; O A da Cruz e Silva; C T Zaia; P Greengard
Journal:  Mol Med       Date:  1995-07       Impact factor: 6.354

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.